Release date: 4 June 2020
Promoter – Financial Intermediary
CREDIT AGRICOLE SALocation
Description
The operation consists in a Multiple Beneficiary Intermediated Loan (MBIL) focusing on the healthcare and pharmaceutical sector in France. 20% will be dedicated to regions where access to medical experts is sub-optimal/underserved.
Objectives
The aim is to facilitate access to long-term finance for projects carried out by professionals and small and medium size enterprises (SMEs) in the healthcare and pharmaceutical sectors.
Sector(s)
- Credit lines - Credit lines
Proposed EIB finance (Approximate amount)
EUR 250 million
Total cost (Approximate amount)
not applicable
Environmental aspects
Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.
Procurement
Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.
Status
Signed - 27/10/2020
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).